RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Christopher Navara to Apoptosis

This is a "connection" page, showing publications Christopher Navara has written about Apoptosis.
Connection Strength

0.106
  1. Mull AN, Klar A, Navara CS. Differential localization and high expression of SURVIVIN splice variants in human embryonic stem cells but not in differentiated cells implicate a role for SURVIVIN in pluripotency. Stem Cell Res. 2014 Mar; 12(2):539-49.
    View in: PubMed
    Score: 0.072
  2. Narla RK, Dong Y, D'Cruz OJ, Navara C, Uckun FM. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent. Clin Cancer Res. 2000 Apr; 6(4):1546-56.
    View in: PubMed
    Score: 0.028
  3. Ghosh S, Zheng Y, Jun X, Narla RK, Mahajan S, Navara C, Mao C, Sudbeck EA, Uckun FM. Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells. Clin Cancer Res. 1998 Nov; 4(11):2657-68.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support